CA1272726C - 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines - Google Patents

2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines

Info

Publication number
CA1272726C
CA1272726C CA 417532 CA417532A CA1272726C CA 1272726 C CA1272726 C CA 1272726C CA 417532 CA417532 CA 417532 CA 417532 A CA417532 A CA 417532A CA 1272726 C CA1272726 C CA 1272726C
Authority
CA
Canada
Prior art keywords
aminocarbonylaminosulfonyl
azetidines
aminocarbonyl
oxo
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 417532
Other languages
English (en)
French (fr)
Other versions
CA1260472A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000583432A priority Critical patent/CA1272726A/en
Application granted granted Critical
Publication of CA1260472A publication Critical patent/CA1260472A/en
Publication of CA1272726C publication Critical patent/CA1272726C/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CA 417532 1982-01-04 1982-12-13 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines Expired - Lifetime CA1272726C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000583432A CA1272726A (en) 1982-01-04 1988-11-17 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33653782A 1982-01-04 1982-01-04
US336,537 1982-01-04
US36860982A 1982-04-15 1982-04-15
US368,609 1982-04-15

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000583432A Division CA1272726A (en) 1982-01-04 1988-11-17 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines

Publications (2)

Publication Number Publication Date
CA1260472A CA1260472A (en) 1989-09-26
CA1272726C true CA1272726C (en) 1990-08-14

Family

ID=26990250

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 417532 Expired - Lifetime CA1272726C (en) 1982-01-04 1982-12-13 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines

Country Status (19)

Country Link
EP (1) EP0085291B1 (Direct)
JP (1) JPS58121269A (Direct)
KR (1) KR890000418B1 (Direct)
AU (1) AU570912B2 (Direct)
CA (1) CA1272726C (Direct)
DD (1) DD207907A5 (Direct)
DE (1) DE3377712D1 (Direct)
DK (1) DK583A (Direct)
ES (1) ES8403108A1 (Direct)
FI (1) FI830017A7 (Direct)
GR (1) GR77135B (Direct)
HU (1) HU188986B (Direct)
IE (1) IE54388B1 (Direct)
IL (1) IL67528A (Direct)
NO (1) NO830003L (Direct)
NZ (1) NZ202891A (Direct)
PH (1) PH21695A (Direct)
PT (1) PT76064A (Direct)
SU (1) SU1391496A3 (Direct)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0117053A1 (en) * 1983-02-10 1984-08-29 Ajinomoto Co., Inc. Azetidinone derivatives
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
KR880701238A (ko) * 1986-05-23 1988-07-26 로버트 에이 아르미티즈 N-1 치환 설포닐아미노카르보닐,c-4 치환 모노박탐
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
JPH02502455A (ja) * 1987-02-27 1990-08-09 ジ・アップジョン・カンパニー ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US5015737A (en) * 1987-07-22 1991-05-14 The Upjohn Company Therapeutically useful beta-lactams
EP0344707A3 (en) * 1988-06-02 1990-04-18 E.R. Squibb & Sons, Inc. 2-Oxo-1-[[(substituted sulfonyl)-amino]carbonyl]-azetidine derivatives
KR20040044920A (ko) * 2001-09-14 2004-05-31 아벤티스 파마슈티칼스 인크. 카뎁신 억제제로서 신규한 화합물 및 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines

Also Published As

Publication number Publication date
FI830017L (fi) 1983-07-05
PH21695A (en) 1988-01-13
GR77135B (Direct) 1984-09-07
ES518758A0 (es) 1984-03-01
IE54388B1 (en) 1989-09-13
DK583A (da) 1983-07-05
NZ202891A (en) 1986-02-21
AU570912B2 (en) 1988-03-31
AU9161782A (en) 1983-07-14
EP0085291B1 (en) 1988-08-17
IE823087L (en) 1983-07-04
HU188986B (en) 1986-05-28
DE3377712D1 (de) 1988-09-22
EP0085291A1 (en) 1983-08-10
KR890000418B1 (ko) 1989-03-17
IL67528A (en) 1986-04-29
ES8403108A1 (es) 1984-03-01
KR840002808A (ko) 1984-07-21
NO830003L (no) 1983-07-05
SU1391496A3 (ru) 1988-04-23
PT76064A (en) 1983-02-01
JPS58121269A (ja) 1983-07-19
DK583D0 (da) 1983-01-03
FI830017A0 (fi) 1983-01-04
FI830017A7 (fi) 1983-07-05
CA1260472A (en) 1989-09-26
DD207907A5 (de) 1984-03-21

Similar Documents

Publication Publication Date Title
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
FR2446289A1 (fr) Compose de 2-penem, procede de preparation et composition pharmaceutique obtenue
EP0259485A4 (en) HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
EP0302525A3 (en) Quinolones as antibacterial agents
MY110747A (en) Quinolone-and naphthyridonecarboxylic acid derivatives
CA1272726C (en) 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
ES470689A1 (es) Un procedimiento para la preparacion de acido 7-metoxi-7- (4-metilen sustituido-1,3-ditietan-2-il-carboxamido)-3-hete-rociclotiometil-3-cefem-4-carboxilico
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
IE831648L (en) Cephalosporin compounds
ES8606374A1 (es) Un procedimiento para preparar derivados de acido neuramini-co
DE3466991D1 (en) Penems, pharmaceutical compositions containing them, and process for their preparation
ES8301928A1 (es) Un procedimiento para preparar 4-(2-4-dicloro-3-metilbenzoil)-1,3-dimetil-5-fenaciloxipirazol).
IL76931A (en) 2-trifluoromethyl-6-haloalkyl-4-heteroatom substituted-3-pyridinecarboxylic acid esters,their preparation,herbicidal compositions comprising them,and some free acid intermediates therefor
IE781568L (en) Cyclopeptide antibiotic
EP0167936A3 (en) Use of actinonin as an immunopotentiator
AU568064B2 (en) 4-acylamino-1-aza-adamantanes
ES8700650A1 (es) Procedimiento para preparar derivados de acidos 7-(ariloxi)-2-naftiloxi-alcancarboxilicos racemicos e isomeros
JPS55104281A (en) Novel 22aminoo88cyclopropyll55oxoo5*88dihydroo pyrido*2*33d*pyrimidinee66carboxulic acid compound
MY103910A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
ES8603434A1 (es) Un procedimiento para la produccion del 1, 2, 4-triazolilpropanol
ES8701182A1 (es) Un procedimiento para preparar sal monosodica del acido 7-d-mandelamido-3-(1-sulfometiltetrazol-5-il)tiometil-3-cefem-4-carboxilico
PT83141A (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds useful as antimicrobial agents
JPS5488240A (en) Novel fortimicin a derivative

Legal Events

Date Code Title Description
MKEX Expiry
MKEX Expiry

Effective date: 20060926